The brief report is the first study of its kind, the researchers say, to establish a link between the use of such drugs, called GLP-1 agonists, for weight loss and the risk of such gastrointestinal conditions
The structural modifications in IGF-1 LR3 may have also contributed to the increased affinity of the peptide towards the IGF-1 receptors
Reprod Biomedicine Online
10.1007/s12010-024-05141-9 90 Malaekeh-NikoueiA.Shokri-NaeiS.KarbasforoushanS.BahariH.Baradaran RahimiV.HeidariR.et al (2023)
Compounded products often do not specify which form is included, and some contain both in a "combo vial." Bioavailability and penetration limits are ignored
Third, as GLP-1 receptor agonists become increasingly utilized, understanding their effects on bone health becomes critical, particularly in older adults and postmenopausal women. Burak Altintas, MD Still, the results dont mean that semaglutide is always the best option when it comes to weight loss